Literature DB >> 18923014

Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.

Carmelo Massimo Maida1, Maria Eleonora Milici, Laura Trovato, Salvatore Oliveri, Emanuele Amodio, Elisabetta Spreghini, Giorgio Scalise, Francesco Barchiesi.   

Abstract

Susceptibility testing of anidulafungin (AFG) against 32 mold isolates showed an excellent correlation between disk diffusion (DD) and broth microdilution methods. Based on our data, a 2-microg disk of AFG and a 24-h reading time might represent the best parameters for AFG DD testing against filamentous fungi.

Mesh：

Substances：

Year:  2008        PMID： 18923014      PMCID： PMC2593298          DOI： 10.1128/JCM.01088-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

Review 2.  Echinocandins: a new class of antifungal.

Authors:  David W Denning
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

3.  Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.

Authors:  Sevtap Arikan; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 4.  Infections due to emerging and uncommon medically important fungal pathogens.

Authors:  T J Walsh; A Groll; J Hiemenz; R Fleming; E Roilides; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

5.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

6.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Authors:  D A Stevens; V L Kan; M A Judson; V A Morrison; S Dummer; D W Denning; J E Bennett; T J Walsh; T F Patterson; G A Pankey
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

Review 7.  Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

Authors:  M M McNeil; S L Nash; R A Hajjeh; M A Phelan; L A Conn; B D Plikaytis; D W Warnock
Journal:  Clin Infect Dis       Date:  2001-07-30       Impact factor: 9.079

8.  Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.

Authors:  T F Patterson; W R Kirkpatrick; M White; J W Hiemenz; J R Wingard; B Dupont; M G Rinaldi; D A Stevens; J R Graybill
Journal:  Medicine (Baltimore)       Date:  2000-07       Impact factor: 1.889

Review 9.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

10.  Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.

Authors:  Maria Eleonora Milici; Carmelo Massimo Maida; Elisabetta Spreghini; Barbara Ravazzolo; Salvatore Oliveri; Giorgio Scalise; Francesco Barchiesi
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948
View more
  4 in total

1.  Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

Authors:  Joseph Meletiadis; Maria Siopi; Lamprini Kanioura; Karin Meinike Jørgensen; David S Perlin; Johan W Mouton; Maiken Cavling Arendrup
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

2.  Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review.

Authors:  Paola Di Carlo; Roberto Pirrello; Giuliana Guadagnino; Pierina Richiusa; Antonio Lo Casto; Caterina Sarno; Francesco Moschella; Daniela Cabibi
Journal:  Case Rep Med       Date:  2014-05-27

3.  Preparation, Characterization, and Antimicrobial Properties of Chitosan-Silver Nanocomposites Films Against Fish Pathogenic Bacteria and Fungi.

Authors:  S H S Dananjaya; D C M Kulatunga; G I Godahewa; Chamilani Nikapitiya; Chulhong Oh; Madurani Edussuriya; Jehee Lee; Mahanama De Zoysa
Journal:  Indian J Microbiol       Date:  2017-08-22       Impact factor: 2.461

4.  In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates.

Authors:  Rosanna Inturri; Laura Trovato; Giovanni Li Volti; Salvatore Oliveri; Giovanna Blandino
Journal:  Heliyon       Date:  2019-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.